Familial recurrent bilateral panuveitis: Efficiency of alpha interferon;Panuvéite bilatérale récidivante familiale: Efficacité de l'interféron alpha

Revue de Medecine Interne

Volumn 24, Issue 7, 2003, Pages 464-468

  Lesire, V ^a   Arsene S ^a   Piquemal, R ^a   Renard, J P ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Alpha interferon; Familial uveitis; Panuveitis

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CYCLOSPORIN; HLA B ANTIGEN; METHYLPREDNISOLONE;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FOLLOW UP; HAPLOTYPE; HUMAN; MALE; RECURRENT DISEASE; SYMPTOM; UVEITIS; VISUAL ACUITY;

EID: 0038125553     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00147-4     Document Type: Article

References (22)

1. Bloch-Michel E, Dussaix E, Guyot F, Cerqueti P, Frau E. L'origine des uvéites: évolution des résultats du bilan étiologique au cours des 20 dernières années (1966-1986). Bull Soc Opht France 1982;6-7:779-81.
2. Darrel RW, Wagener HP, Kurland LT. Epidemiology of uveitis, Incidence and prevalence in a small community. Arch Ophtalmol 1962;68:502.
3. Ohno S, Kimura SJ, O'Connor R, Char DH. HLA antigens and uveitis. Br J Ophtalmol 1977;61:62-4.
4. Levecq L, Disneur D, Dutrieux C, Snyers B. Étiologies des panuvéites et des uvéites intermédiaires et postérieures: une revue de 201 observations. Bull Soc Belge Ophtamol 1999;273:9-14.
5. Fresard A, Cathebras P, Maugery J, Rousset H. Les uvéites: aspects étiologiques. Rev Med Interne 1989;10:442-8.
6. Bodaghi B, Cassoux N, Wechsler B, Hannouche D, Fardeau C, Papo T, et al. Chronic severe uveitis, Etiology and visual outcome in 927 patients from a single center. Medicine 2001;80:263-70.
7. Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJ, Linssen A, Alberts C, et al. Uveitis and systemic disease. Br J Ophtalmol 1992;76:137-41.
8. Weiner A, Ben Ezra D. Clinical patterns and associated conditions in chronic uveitis. Am J Ophtalmol 1991;112:151-8.
9. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999;341:1284-91.
10. Moorthy RS, Valluri S, Jampol LM. Drug-induced uveitis. Surv Ophtalmol 1998;42:557-70.
11. Rothova A, Ooijman F, Kerkhoff F, Van der Lelij A, Lokhorst HM. Uveitis masquerade syndromes. Ophtalmology 2001;108:389-99.
12. Castier P, François M, Duret MH. Uvéite familiale. Bull Soc Opht France 1982;10:1277-9.
13. Tohme A, El Khoury I, Ghayad E. La maladie de Behçet. Presse Med 1999;28:1080-4.
14. Yazici H, Pazarli H, Barnes CG, Tüzün Y, Özyazgan Y, Silman A, et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990;322:281-5.
15. De Vries J, Baarsma GS, Zaal MJ, Boen-Tan TN, Rothova A, Buitenhuis HJ, et al. Cyclosporin in the treatment of severe chronic idiopathic uveitis. Br J Ophtalmol 1990;74:344-9.
16. Sullu Y, Oge I, Erkan D, Ariturk N, Mohajeri F. Cyclosporin A therapy in severe uveitis of Behçet's disease. Acta Ophtalmol Scand 1998;76:96-9.
17. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporin. Ophtalmology 1999;106:723-8.
18. Belardelli F, Gresser I. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol Today 1996;17:369-72.
19. Kotter I, Eckstein AK, Stubiger N, Zierhut M. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study. Br J Ophtalmol 1998;82:488-94.
20. Wechsler B, Bodaghi B, Huong DL, Fardeau C, Amoura Z, Cassoux N, et al. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease. Ocul Immunol Inflam 2000;8:293-301.
21. Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alpha. Arch Ophtalmol 1995;113:1041-4.
22. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet 2001;3258:295-6.